SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer

Overview of attention for article published in Oncogene, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet

twitter: 10 X users

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 523,198 followers.

A few reviews of recent SHP2 inhibitor clinical trials: https://t.co/0gyBNQnECH https://t.co/Pvb7LIbmMK

Congrats to everyone who worked hard to publish this in @oncogenejournal 🎉 https://t.co/o6JWjpm4Wh

RT @WendtLab_cancer: Congrats to to Hao Chen on a great piece of work and a big thanks to all the collaborators. Excited to see continued p…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.